Both GSTM2 and GSTP1 promoters were among the top 1% of promoters whose methylation is most strongly correlated with TMB in prostate cancer (Supplementary Figure S7C) demonstrating that this association is specific for these genes. This evidence concerns the gene GSTP1 and prostate cancer.